Applying Synthetic Biology To Orphan Drug Development

2020 Harvard President's Challenge Finalist (LifeScience Track)

Our product candidates are designed to improve detection, visualization and treatment of rare diseases of The Alimentary Track. We plan to file IND's With the US FDA and Other Appropriate Regulatory Authorities to Support Their Clinical Development.

​

SB-101 Is Designed to Significantly Improve Colonoscopy Outcomes for Lynch Syndrome Patients 

SB-201 Is a Potential New Therapeutic Paradigm for The Treatment of Familial Adenomatous Polyposis